2009
DOI: 10.1124/pr.109.001073
|View full text |Cite
|
Sign up to set email alerts
|

Therapeutic Targeting of Toll-Like Receptors for Infectious and Inflammatory Diseases and Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
359
0
8

Year Published

2011
2011
2016
2016

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 390 publications
(368 citation statements)
references
References 222 publications
1
359
0
8
Order By: Relevance
“…required for the induction of BMP-2 expression by oxLDL as TLR2 and TLR4 utilize this shared signaling pathway (34).…”
Section: Discussionmentioning
confidence: 99%
“…required for the induction of BMP-2 expression by oxLDL as TLR2 and TLR4 utilize this shared signaling pathway (34).…”
Section: Discussionmentioning
confidence: 99%
“…A toll-like receptor (TLR) family on intestinal epithelial cells plays an important role in recognizing the intestine foreigners, which subsequently initiates the inflammation response Kawai & Akira 2009;O'Neill et al 2009;Lavelle et al 2010). MyD88 is the main adaptor molecule of TLRs; most of signal transduction of TLRs needs MyD88 to activate the downstream molecules, and finally leads nuclear factors such as NF-κB enter into nuclear and regulate inflammatory cytokines expression.…”
Section: Introductionmentioning
confidence: 99%
“…According to crystal structures, TLRs form homo-or heterodimeric signaling complexes interacting with the single PAMP molecule [3][4][5][6][7]. The medical and biological significance of toll-like receptor (TLR) signaling is obvious, since the disregulation of the TLR system may cause various autoimmune diseases and septic shock [8][9][10][11], and some therapeutic strategies targeting TLRs have already emerged [8,11,12].…”
Section: Introductionmentioning
confidence: 99%